Sab Biotherapeutics Inc (SABS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SABS | ACTU | MXCT | ||
| Company | Sab Biotherapeutics Inc | Actuate Therapeutics Inc | Maxcyte Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.54 | 7.46 | 1.6100 | ||
| High | 3.89 | 7.64 | 1.6100 | ||
| Low | 3.54 | 7.30 | 1.5000 | ||
| Latest | 3.81 | 7.52 | 1.5200 | ||
| Change | +0.22 | +0.10 | -0.0800 | ||
| % Change | +6.13% | +1.35% | -5.00% | ||
| Volume | 150,100 | 104,600 | 1,180,500 | ||
| 20-Day Average Volume | 254,040 | 76,360 | 1,606,600 | ||
| Previous Close | 3.59 | 7.42 | 1.6000 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.78 | 6.87 | 1.6160 | ||
| 20-Day Raw Stochastic | 68.07% | 83.41% | 25.97% | ||
| 20-Day Relative Strength | 57.44 | 57.45 | 46.48 | ||
| Weighted Alpha | +44.01 | -14.00 | -54.71 | ||
| Today's Opinion | 100% Buy | 40% Sell | 48% Sell | ||
| Previous Opinion | 88% Buy | 40% Sell | 48% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.27% since 12/05/25 | +2.31% since 12/05/25 | +3.40% since 12/05/25 | ||
| Low | 3.30 on 12/08/25 | 6.89 on 12/10/25 | 1.4900 on 12/08/25 | ||
| High | 4.01 on 12/08/25 | 7.90 on 12/10/25 | 1.6100 on 12/12/25 | ||
| 1-Month | |||||
| %Chg | +11.73% since 11/12/25 | +19.37% since 11/12/25 | -3.80% since 11/12/25 | ||
| Low | 3.00 on 11/14/25 | 5.61 on 11/20/25 | 1.4200 on 12/05/25 | ||
| High | 4.19 on 11/28/25 | 7.90 on 12/10/25 | 1.8050 on 11/19/25 | ||
| 3-Month | |||||
| %Chg | +79.72% since 09/12/25 | +12.74% since 09/12/25 | +4.83% since 09/12/25 | ||
| Low | 1.85 on 09/30/25 | 5.61 on 11/20/25 | 1.3704 on 11/05/25 | ||
| High | 4.19 on 11/28/25 | 8.49 on 10/10/25 | 1.8650 on 10/16/25 | ||
| 6-Month | |||||
| %Chg | +108.08% since 06/12/25 | -12.66% since 06/12/25 | -33.04% since 06/12/25 | ||
| Low | 1.60 on 06/13/25 | 5.47 on 07/21/25 | 1.2600 on 08/12/25 | ||
| High | 6.60 on 07/21/25 | 9.22 on 09/04/25 | 2.3700 on 07/23/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 170,909 | 172,463 | 170,678 | ||
| Shares Outstanding, K | 47,607 | 23,243 | 106,674 | ||
| Annual Sales | 1,320,000 | 0 | 38,630,000 | ||
| Annual Net Income | -34,110,000 | -27,290,000 | -41,060,000 | ||
| Last Quarter Sales | 0 | 0 | 6,830,000 | ||
| Last Quarter Net Income | 45,450,000 | -5,410,000 | -12,420,000 | ||
| 60-Month Beta | 0.58 | -0.34 | 1.22 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 11/14/25 | -0.25 on 11/13/25 | -0.12 on 11/12/25 | ||
| Latest Earnings Date | 03/27/26 | 03/12/26 | 03/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||